Photosensitive drug eruption induced by efavirenz in a patient with HIV infection

Internal Medicine

Volumn 43, Issue 7, 2004, Pages 533-

  Furue, Masutaka ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Efavirenz; HIV infection; Photosensitive drug eruption

Indexed keywords

EFAVIRENZ; LOPINAVIR PLUS RITONAVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AWARENESS; DRUG ERUPTION; DRUG WITHDRAWAL; EDITORIAL; ERYTHEMA; FACE DISORDER; FOREARM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NECK; PATCH TEST; PHOTOSENSITIVITY; PHYSICIAN; PRURITUS; QUALITY OF LIFE; SKIN EDEMA; SUN EXPOSURE; ULTRAVIOLET A RADIATION;

ANTI-HIV AGENTS; DERMATITIS, PHOTOALLERGIC; DRUG ERUPTIONS; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; JAPAN; MALE; MIDDLE AGED; OXAZINES; RISK ASSESSMENT;

EID: 19344373643     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.43.533     Document Type: Editorial

References (4)

1. Tonnerre P, Delmotte H. Undesirable effects of AIDS treatments. Rev Infirm 94: 12-15, 2003.
2. Tan A, Tan HH, Lee CC, Ng SK. Treatment of toxic epidermal necrolysis in AIDS with intravenous immunoglobulins. Clin Exp Dermatol 28: 269-271, 2003.
3. Eliaszewicz M, Flahault A, Roujeau JC, et al. Epitox Study Group. Prospective evaluation of risk factors of cutaneous drug reactions to sulfonamides in patients with AIDS. J Am Acad Dermatol 47: 40-46, 2002.
4. Yoshimoto E, Konishi M, Takahashi K, et al. The first case of efavirenz-induced photosensitivity in a Japanese patient with HIV infection. Intern Med 43: 630-631, 2004.